CYNTHIA JANTZEN: Open Payments
NPI 1932158730 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 104 payments from 16 companies in 2025. Trend: 2023 $1,641 · 2024 $1,764 · 2025 $1,764
Food & beverage: $1,713Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $489 |
| Janssen Biotech, Inc. | 17 | $257 |
| Lilly USA, LLC | 8 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $166 |
| GENZYME CORPORATION | 4 | $88 |
| Celltrion USA Inc. | 4 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Madrigal Pharmaceuticals | 4 | $72 |
| Gilead Sciences, Inc. | 3 | $64 |
| Ardelyx, Inc. | 3 | $63 |
Products named: TREMFYA, OMVOH, ENTYVIO, SKYRIZI, CREON, DUPIXENT, LINZESS, RINVOQ.
Industry payments across KS — which companies pay providers there.
